To further explore the role of the CD4-GZMA cell subset in HCC development, we analyzed the differentially expressed genes (DEGs) between high and low CD4-GZMA cell infiltrated groups and further performed GO and Pathway analysis. The gene discussed is CD4; the disease is hepatocellular carcinoma.